Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The Ullrich-Turner syndrome]

O Butenandt

    Fortschritte Der Medizin
    |July 3, 1980
    PubMed
    Summary

    Ullrich-Turner syndrome, a chromosomal abnormality (45 XO), causes stunted growth, deformities, and primary amenorrhea. Treatment involves steroids and hormone replacement, but final height is limited and infertility is common.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Statistical tricks. Can a proband be minus 2 years old?].

    MMW Fortschritte der Medizin·2006
    Same author

    Persistent papilledema in Ullrich-Turner syndrome treated with growth hormone.

    Clinical pediatrics·2002
    Same author

    GH therapy in juvenile chronic arthritis: results of a two-year controlled study on growth and bone.

    The Journal of clinical endocrinology and metabolism·2001
    Same author

    Elevated nerve growth factor and neurotrophin-3 levels in cerebrospinal fluid of children with hydrocephalus.

    BMC pediatrics·2001
    Same author

    [Lymphedema. In Ullrich-Turner syndrome it is congenital].

    MMW Fortschritte der Medizin·2001
    Same author

    Childhood onset of GH deficiency: reassessment of GH status and effects of substitution.

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society·2000

    Area of Science:

    • Genetics
    • Endocrinology
    • Pediatrics

    Context:

    • Ullrich-Turner syndrome is a genetic disorder affecting females.
    • Characterized by a chromosomal abnormality, most commonly 45 XO karyotype.

    Purpose:

    • To outline the etiology, clinical manifestations, and management of Ullrich-Turner syndrome.
    • To provide an overview of treatment strategies and expected outcomes.

    Summary:

    • The primary cause is chromosomal anomaly (45 XO), leading to gonadal dysgenesis.
    • Clinical features include stunted growth, pterygium colli, cubita valga, and primary amenorrhea.
    • Treatment involves anabolic steroids for growth and estrogen therapy, with limited final height and infertility.

    Impact:

    • Informs clinical practice regarding diagnosis and management of Ullrich-Turner syndrome.
    • Highlights the importance of early intervention for growth and development.
    • Sets expectations for patients and families regarding prognosis and potential fertility issues.

    Related Experiment Videos